Contact UsCareers
Top bar

Participating in clinical trials

As part of our commitment to developing safe and effective therapies, we are conducting clinical trials of our investigational medicines. We thank patients who choose to participate in clinical trials, as you play a critical role in developing new medicines and transforming the treatment landscape for rare and aggressive cancers.

 

If you are interested in gaining access to our investigational medicines, please contact Ayala Medical at clinicaltrials@ayalapharma.com or call +1-857-444-0553.

 

Our investigational product candidates have been and are being evaluated in clinical trials at leading oncology centers across the United States, Europe and Canada.

Details of the trial locations can be found here.

bar

Am I a Candidate?

Currently, we are conducting a Phase 2 clinical trial for Recurrent/Metastatic Adenoid Cystic Carcinoma (R/M ACC), and a Phase 2 clinical trial for recurrent/metastatic triple negative breast cancer (R/M TNBC).

If you have recurrent or metastatic Adenoid Cystic Carcinoma, but not amenable to potentially curative surgery or radiotherapy, you may be eligible to participate in our Phase 2 ACCURACY clinical trial. Your tumor must test positive for NOTCH activating mutations for you to be included in the trial.

If you have recurrent or metastatic Triple Negative Breast Cancer, not amenable to potentially curative surgery, and have been treated with up to three lines of therapy, you may be eligible to participate in our Phase 2 TENACITY clinical trial. Your tumor must test positive for certain NOTCH activating alterations for you to be included in the trial.